Han Ying
Clinical trials sponsored by Han Ying, explained in plain language.
-
New combo therapy aims to help Hard-to-Treat PBC patients
Disease control ENROLLING_BY_INVITATIONThis study looks at whether adding the steroid prednisone to the usual medicine (ursodeoxycholic acid) can improve outcomes for people with primary biliary cholangitis (PBC) who also have moderate to severe liver inflammation. About 244 adults with PBC will take either the combin…
Phase: PHASE2, PHASE3 • Sponsor: Han Ying • Aim: Disease control
Last updated May 26, 2026 10:24 UTC
-
Liver disease hope: drug combo shows promise in PBC trial
Disease control OngoingThis study tests whether adding fenofibrate to the standard treatment (ursodeoxycholic acid) can improve liver function in people with primary biliary cholangitis (PBC), a chronic liver disease. About 184 adults aged 18-75 with PBC are taking part. The main goal is to see if the …
Phase: PHASE2, PHASE3 • Sponsor: Han Ying • Aim: Disease control
Last updated May 22, 2026 14:03 UTC